Yun Lü

1.1k total citations
33 papers, 657 citations indexed

About

Yun Lü is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yun Lü has authored 33 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Yun Lü's work include Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yun Lü is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yun Lü collaborates with scholars based in China and United States. Yun Lü's co-authors include Shaozhi Fu, Kang Xiong, Zhouxue Wu, Biqiong Wang, Ling Zhao, Jia Luo, Qian Wen, Yue Li, Yue Chen and Ping Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and The Journal of Physical Chemistry.

In The Last Decade

Yun Lü

31 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun Lü China 16 245 182 169 126 74 33 657
Abbas Alibakhshi Iran 15 388 1.6× 274 1.5× 203 1.2× 51 0.4× 57 0.8× 37 840
Yongxin Li China 13 290 1.2× 267 1.5× 203 1.2× 88 0.7× 16 0.2× 39 794
Chuanchuan He China 20 364 1.5× 448 2.5× 524 3.1× 204 1.6× 88 1.2× 35 1.1k
Sungchul Kim South Korea 9 239 1.0× 478 2.6× 280 1.7× 63 0.5× 22 0.3× 12 864
Cristina Fonseca Portugal 9 219 0.9× 413 2.3× 185 1.1× 29 0.2× 35 0.5× 31 820
Tushar Date India 14 201 0.8× 190 1.0× 103 0.6× 40 0.3× 20 0.3× 22 493
Shu‐Jin Li China 13 290 1.2× 110 0.6× 316 1.9× 63 0.5× 14 0.2× 22 742
Abdullah Farooque India 13 332 1.4× 204 1.1× 164 1.0× 131 1.0× 16 0.2× 20 878
Derek J. Quinn United Kingdom 16 552 2.3× 142 0.8× 102 0.6× 100 0.8× 63 0.9× 34 957
Baofeng Yu China 16 275 1.1× 86 0.5× 138 0.8× 53 0.4× 10 0.1× 48 641

Countries citing papers authored by Yun Lü

Since Specialization
Citations

This map shows the geographic impact of Yun Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Lü more than expected).

Fields of papers citing papers by Yun Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Lü. The network helps show where Yun Lü may publish in the future.

Co-authorship network of co-authors of Yun Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Lü. A scholar is included among the top collaborators of Yun Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Lü. Yun Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Jie, Renjin Chen, Jie Wang, et al.. (2024). Intraperitoneal administration of doxorubicin-encapsulated Brucea javanica oil nanoemulsion against malignant ascites. European Journal of Pharmaceutics and Biopharmaceutics. 202. 114422–114422. 2 indexed citations
2.
Lü, Yun, et al.. (2022). Hydroxychloroquine-induced acute generalized exanthematous pustulosis in a patient with systemic lupus erythematosus. Visual Journal of Emergency Medicine. 27. 101334–101334.
3.
Zeng, Qibing, et al.. (2022). The Epidemiological Characteristics of Noncommunicable Diseases and Malignant Tumors in Guiyang, China: Cross-sectional Study. JMIR Public Health and Surveillance. 8(10). e36523–e36523. 2 indexed citations
4.
5.
6.
Hu, Hui, Chao Liu, Yumei Zhao, et al.. (2022). Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma. Scientific Reports. 12(1). 10401–10401. 10 indexed citations
7.
Li, Xiangyü, Kai Zhao, Yun Lü, Jianming Wang, & Wei Yao. (2022). Genetic Analysis of Platelet-Related Genes in Hepatocellular Carcinoma Reveals a Novel Prognostic Signature and Determines PRKCD as the Potential Molecular Bridge. Biological Procedures Online. 24(1). 22–22. 10 indexed citations
8.
Wang, Xuanxuan, et al.. (2022). Drug-induced liver injury associated with dacomitinib: A case report. Frontiers in Oncology. 12. 979462–979462. 5 indexed citations
9.
Lü, Yun, et al.. (2022). Global landscape of 2-hydroxyisobutyrylation in human pancreatic cancer. Frontiers in Oncology. 12. 1001807–1001807. 15 indexed citations
10.
Li, Yue, Ping Zhou, Kang Xiong, et al.. (2021). Injectable hydrogel loaded with paclitaxel and epirubicin to prevent postoperative recurrence and metastasis of breast cancer. Materials Science and Engineering C. 129. 112390–112390. 49 indexed citations
11.
Li, Yue, Biqiong Wang, Zhouxue Wu, et al.. (2020). Curcumin nanoparticles incorporated in PVA/collagen composite films promote wound healing. Drug Delivery. 27(1). 1676–1685. 59 indexed citations
12.
Xiong, Kang, Qian Wen, Jia Luo, et al.. (2020). Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy. International Journal of Pharmaceutics. 589. 119875–119875. 77 indexed citations
13.
Zhao, Yumei, Peng Wu, Lantu Gou, et al.. (2020). <p>HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma</p>. International Journal of Nanomedicine. Volume 15. 6409–6420. 13 indexed citations
14.
Jiang, Zhijie, Hui Xiong, Shan Yang, et al.. (2020). Jet‐Lagged Nanoparticles Enhanced Immunotherapy Efficiency through Synergistic Reconstruction of Tumor Microenvironment and Normalized Tumor Vasculature. Advanced Healthcare Materials. 9(12). e2000075–e2000075. 36 indexed citations
15.
Luo, Jia, Zhouxue Wu, Yun Lü, et al.. (2020). Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis. International Journal of Biological Macromolecules. 152. 718–726. 24 indexed citations
16.
Wen, Qian, Jia Luo, Kang Xiong, et al.. (2020). Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites. International Journal of Pharmaceutics. 582. 119334–119334. 40 indexed citations
17.
Lü, Yun, Yuanyuan Xu, Min Li, et al.. (2018). Whole-exome Sequencing Helps the Diagnosis and Treatment in Children with Neurodevelopmental Delay Accompanied Unexplained Dyspnea. Scientific Reports. 8(1). 5214–5214. 32 indexed citations
18.
Lü, Yun, et al.. (2017). LncRNA UCA1 promotes renal cell carcinoma proliferation through epigenetically repressing p21 expression and negatively regulating miR-495. Tumor Biology. 39(5). 3726131763–3726131763. 32 indexed citations
19.
Shen, Yun, et al.. (2016). Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System. Current Stem Cell Research & Therapy. 11(3). 208–215. 1 indexed citations
20.
Luján, Hugo D., Michael R. Mowatt, Jingjing Wu, et al.. (1995). Purification of a Variant-specific Surface Protein of Giardia lamblia and Characterization of its Metal-binding Properties. Journal of Biological Chemistry. 270(23). 13807–13813. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abbas Alibakhshi Breakdown of academic impact, for papers by Yongxin Li Breakdown of academic impact, for papers by Chuanchuan He Breakdown of academic impact, for papers by Sungchul Kim Breakdown of academic impact, for papers by Cristina Fonseca Breakdown of academic impact, for papers by Tushar Date Breakdown of academic impact, for papers by Shu‐Jin Li Breakdown of academic impact, for papers by Abdullah Farooque Breakdown of academic impact, for papers by Derek J. Quinn Breakdown of academic impact, for papers by Baofeng Yu
Rankless by CCL
2026